Location History:
- New South Wales, AU (2022)
- The University of Sydney, AU (2022)
Company Filing History:
Years Active: 2022
Title: Eryn Werry: Innovator in Neurological Treatments
Introduction
Eryn Werry is a prominent inventor based in New South Wales, Australia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating neurological and psychiatric disorders. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Eryn Werry's latest patents include groundbreaking research on non-peptide oxytocin receptor agonists. These compounds, described in her patent, are designed to treat neurological and psychiatric disorders characterized by disruptions in social behavior and substance use disorders. Additionally, she has developed metabolite-inspired selective oxytocin receptor agonists, which are cyclic metabolites of oxytocin that exhibit enhanced selectivity for the oxytocin receptor. These advancements hold promise for improving treatment options in mental health.
Career Highlights
Eryn Werry has established herself as a key figure in the pharmaceutical industry through her innovative research and development efforts. Her work at Kinoxis Therapeutics Pty Ltd has been instrumental in advancing the understanding of oxytocin's role in social behavior and its potential therapeutic applications.
Collaborations
Eryn has collaborated with notable colleagues, including Michael Kassiou and Tristan Reekie, to further her research initiatives. Their combined expertise has contributed to the success of her projects and the advancement of their shared goals in the field of neuroscience.
Conclusion
Eryn Werry's contributions to the field of pharmaceutical sciences are noteworthy and impactful. Her innovative patents and collaborative efforts are setting new standards in the treatment of neurological and psychiatric disorders.